ADHD Therapeutics Market Report

Global and Region ADHD Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：139
  • REPORT CODE：GMM880939
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of ADHD Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of ADHD Therapeuticsmarket, defines the market attractiveness level of ADHD Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of ADHD Therapeutics industry, describes the types of ADHD Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global ADHD Therapeutics market and the development prospects and opportunities of ADHD Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global ADHD Therapeutics market in Chapter 13.

    By Player:

    • Shire

    • Mallinckrodt Pharmaceuticals

    • Eli Lilly

    • UCB SA

    • GlaxoSmithKline

    • Novartis

    • Purdue Parma

    • Impax Laboratories

    • Johnson & Johnson

    • Pfizer

    • Hisamitsu Pharmaceutical

    By Type:

    • Stimulants

    • Non-stimulants

    By End-User:

    • Specialty Clinics

    • Hospital Pharmacies

    • Retail Pharmacies

    • E-Commerce

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 ADHD Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 ADHD Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 ADHD Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 ADHD Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise ADHD Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global ADHD Therapeutics Consumption (2017-2022)

    • 7.2 United States ADHD Therapeutics Consumption (2017-2022)

    • 7.3 Europe ADHD Therapeutics Consumption (2017-2022)

    • 7.4 China ADHD Therapeutics Consumption (2017-2022)

    • 7.5 Japan ADHD Therapeutics Consumption (2017-2022)

    • 7.6 India ADHD Therapeutics Consumption (2017-2022)

    • 7.7 South Korea ADHD Therapeutics Consumption (2017-2022)

    8 Region and Country-wise ADHD Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India ADHD Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea ADHD Therapeutics Consumption Forecast (2022-2028)

    9 Global ADHD Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global ADHD Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Stimulants Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-stimulants Consumption and Growth Rate (2017-2022)

    • 9.2 Global ADHD Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global E-Commerce Consumption and Growth Rate (2017-2022)

    10 Global ADHD Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global ADHD Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-stimulants Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global ADHD Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)

    11 Global ADHD Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global ADHD Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global ADHD Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 ADHD Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global ADHD Therapeutics Market Competitive Analysis

    • 14.1 Shire

      • 14.1.1 Shire Company Details

      • 14.1.2 Shire ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Shire ADHD Therapeutics Product and Service

    • 14.2 Mallinckrodt Pharmaceuticals

      • 14.2.1 Mallinckrodt Pharmaceuticals Company Details

      • 14.2.2 Mallinckrodt Pharmaceuticals ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Mallinckrodt Pharmaceuticals ADHD Therapeutics Product and Service

    • 14.3 Eli Lilly

      • 14.3.1 Eli Lilly Company Details

      • 14.3.2 Eli Lilly ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lilly ADHD Therapeutics Product and Service

    • 14.4 UCB SA

      • 14.4.1 UCB SA Company Details

      • 14.4.2 UCB SA ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 UCB SA ADHD Therapeutics Product and Service

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Details

      • 14.5.2 GlaxoSmithKline ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline ADHD Therapeutics Product and Service

    • 14.6 Novartis

      • 14.6.1 Novartis Company Details

      • 14.6.2 Novartis ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis ADHD Therapeutics Product and Service

    • 14.7 Purdue Parma

      • 14.7.1 Purdue Parma Company Details

      • 14.7.2 Purdue Parma ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Purdue Parma ADHD Therapeutics Product and Service

    • 14.8 Impax Laboratories

      • 14.8.1 Impax Laboratories Company Details

      • 14.8.2 Impax Laboratories ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Impax Laboratories ADHD Therapeutics Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson ADHD Therapeutics Product and Service

    • 14.10 Pfizer

      • 14.10.1 Pfizer Company Details

      • 14.10.2 Pfizer ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pfizer ADHD Therapeutics Product and Service

    • 14.11 Hisamitsu Pharmaceutical

      • 14.11.1 Hisamitsu Pharmaceutical Company Details

      • 14.11.2 Hisamitsu Pharmaceutical ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Hisamitsu Pharmaceutical ADHD Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of ADHD Therapeutics

    • Figure ADHD Therapeutics Picture

    • Table Global ADHD Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ADHD Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ADHD Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global ADHD Therapeutics Consumption by Country (2017-2022)

    • Figure United States ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea ADHD Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global ADHD Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea ADHD Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Non-stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global E-Commerce Consumption and Growth Rate (2017-2022)

    • Figure Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)

    • Table Global ADHD Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global ADHD Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire ADHD Therapeutics Product and Service

    • Table Mallinckrodt Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Pharmaceuticals ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Pharmaceuticals ADHD Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly ADHD Therapeutics Product and Service

    • Table UCB SA (Foundation Year, Company Profile and etc.)

    • Table UCB SA ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB SA ADHD Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline ADHD Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis ADHD Therapeutics Product and Service

    • Table Purdue Parma (Foundation Year, Company Profile and etc.)

    • Table Purdue Parma ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Parma ADHD Therapeutics Product and Service

    • Table Impax Laboratories (Foundation Year, Company Profile and etc.)

    • Table Impax Laboratories ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Impax Laboratories ADHD Therapeutics Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson ADHD Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer ADHD Therapeutics Product and Service

    • Table Hisamitsu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Hisamitsu Pharmaceutical ADHD Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hisamitsu Pharmaceutical ADHD Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US